Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Acut oral: LD50 rat; male: 2.61 ml/kg bw (Löser, 1981);
Acut inhalation: LC 50 rat; male female: 42 mg/m³ air (LC 50 male: 58 mg/m³air; LC 50 female: 39 mg/m³) (Pauluhn, 1991).
Acut dermal: LD50 rat, male: >2.5 ml/kg (Löser, 1982).

Key value for chemical safety assessment

Additional information

In an acute oral toxicity study in male Wistar rats the animals were treated once via gavage with following doses of test substance: 0.5, 1.0, 3.1, 4.0, 4.5, 5.0 ml/kg bw. Following symptoms of toxicity could be observed in the animals tested: diminuated general condition, cyanosis, narcosis, scrubby fur and bloody eyes and nose.

The LD 50 was found to be: 2.61 ml/kg bw (Löser, 1981).

In an acute oral toxicity study in male and female rats according OECD guideline 403 the animals were exposed for 4h to following concentrations of test substance: 8, 39, 77, 150, 181 mg/m³. The observation period was 4 weeks.

The LC50 for male and female rats was 42 mg/m³ air (LC 50 male: 58 mg/m³air; LC 50 female: 39 mg/m³) (Pauluhn, 1991).

In an acute dermal toxicity test in male rats the test substance was applied once to the skin of the animals. The doses tested were: 1.0 and 2.5 ml/kg bw. The observation period was 14 days. Following signs of toxicity were observed: skin-necrosis, loss of body weight, pain-sensation and diminuation of general condition.

The LD50 was found to be >2.5 ml/kg bw (Löser, 1982).

Justification for classification or non-classification

The LC 50 of 42 mg/m³ leads to a classification requirement of R26.

No classification for acute oral or dermal toxicity required.